News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 73–108
- Matches
- 1595
- Sources here
- 14
- Companies here
- 25
Active search
1595 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Kestra Medical Technologies (KMTS) Nears Its Fair Value, Is The Stock Already Fully Valued?
Kestra Medical Technologies (KMTS) has seen recent positive share price momentum, with its stock closing at US$27.74. While a common narrative suggests the stock is undervalued with a fair value of $28 based on ambitious growth assumptions, other metrics like the P/S ratio indicate …
The Triple-Tax HSA Strategy Doctors Max Before Their 401(k) in 2026
Quick Read The HSA is the only account delivering all three tax advantages: deductible contributions (including FICA savings), tax-free growth, and tax-free qualified withdrawals. Invest HSA funds in equity index funds, pay current medical bills from cash, and save receipts to reimburse yourself tax-free …
Sharemaestro market context Price below Trend Line 52 weeks -69.2% · Next-week setup negative 42.5%MicroStrategy sends harsh response to fresh MSCI delisting threat
Strategy (Nasdaq: MSTR), the world's leading Bitcoin (BTC) treasury company led by billionaire Michael Saylor, faces another MSCI (formerly Morgan Stanley Capital International) delisting threat as the index provider opened a new consultation on the eligibility of non-operating companies for its Global Investable Market …
Stratasys Q2 Earnings Beat, Revenues Miss on Weak System Sales
Stratasys (SSYS) reported flat Q2 2026 non-GAAP earnings of 3 cents per share, beating analyst estimates, though revenues of $137.61 million missed expectations due to weaker system sales. The company saw record consumables revenues and significant growth in aerospace and defense, while facing currency …
Strategy (MSTR) Stock Still Looks Undervalued After a 180% Run
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Strategy stock has surged over the past three years, yet on today's numbers it …
Lite Strategy, Inc. (NASDAQ: LITS) Share Price, LITS Stock News, LITS Share Price & Updates
This article provides stock information for Lite Strategy, Inc. (NASDAQ: LITS), detailing its share price, recent changes, active day range, and 52-week range. It also includes fundamental data such as previous close, market cap, volume, and revenue. The content emphasizes that the information is …
T. Rowe Price Associates (KMTS) discloses 4.97M Kestra Medical shares in 13G/A
T. Rowe Price Associates, Inc. has disclosed a beneficial ownership of 4,968,900 shares of Kestra Medical Technologies common stock, representing 8.5% of the class as of June 30, 2026. The firm holds sole voting power over 4,966,936 shares and sole dispositive power over all …
NEXPOINT DIVERSIFIED REAL ESTATE TRUST 3Q 2026: Revenue $19.3M, EPS $0.06— 10-Q Summary
NEXPOINT DIVERSIFIED REAL ESTATE TRUST (NXDT) reported its Q3 2026 results, showing revenue of $19.3 million and diluted FFO per share of $0.06. The company achieved net income attributable to common shareholders of $0.06 million, a significant improvement from a loss in the prior …
AstraZeneca slips Friday, underperforms market
AstraZeneca PLC (AZN) shares fell 2.12% to £114.60 on Friday, underperforming the broader market as the FTSE 100 Index also declined. The company's stock closed significantly below its 52-week high, which was achieved earlier in the year.
Strata critical medical director Reginald Love disposes of $29,273 in stock
Reginald Love, a director at Strata Critical Medical (NASDAQ:SRTA), sold 5,091 shares of the company's Class A common stock for a total of $29,273 on August 10, 2026. Following this transaction, Love still directly holds 146,481 shares. The company's stock has seen significant gains …